← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 9, 2018Last known activity
Jan 3, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (16 distinct, 8 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT07303699CollaboratorPhase 2Jan 3, 2026
- NCT07185399CollaboratorPhase 4Oct 13, 2025
- NCT06554522CollaboratorPhase 4Oct 1, 2024
- NCT06579690CollaboratorPhase 3Sep 1, 2024
- NCT06199921CollaboratorPhase 2Jan 3, 2024
- NCT05949190CollaboratorN/AAug 18, 2023
- NCT05808166CollaboratorPhase 2May 31, 2023
- NCT03389555CollaboratorPhase 2/Phase 3Feb 9, 2018
Details
- Last known activity
- Jan 3, 2026